Document is current
Any future updates will be listed below
-
Authors
Jones, Samuel E. http://orcid.org/0000-0003-0153-922X
Lane, Jacqueline M.
Wood, Andrew R.
van Hees, Vincent T. http://orcid.org/0000-0003-0182-9008
Tyrrell, Jessica
Beaumont, Robin N. http://orcid.org/0000-0003-0750-8248
Jeffries, Aaron R. http://orcid.org/0000-0002-1235-8291
Dashti, Hassan S. http://orcid.org/0000-0002-1650-679X
Hillsdon, Melvyn
Ruth, Katherine S. http://orcid.org/0000-0003-4966-9170
Tuke, Marcus A. http://orcid.org/0000-0003-0008-9263
Yaghootkar, Hanieh
Sharp, Seth A.
Jie, Yingjie
Thompson, William D.
Harrison, Jamie W. http://orcid.org/0000-0002-8314-9411
Dawes, Amy
Byrne, Enda M. http://orcid.org/0000-0002-9491-7797
Tiemeier, Henning
Allebrandt, Karla V.
Bowden, Jack
Ray, David W. http://orcid.org/0000-0002-4739-6773
Freathy, Rachel M.
Murray, Anna
Mazzotti, Diego R.
Gehrman, Philip R.
Lawlor, Debbie A. http://orcid.org/0000-0002-6793-2262
Frayling, Timothy M.
Rutter, Martin K.
Hinds, David A. http://orcid.org/0000-0002-4911-803X
Saxena, Richa http://orcid.org/0000-0003-2233-1065
Weedon, Michael N.
- License Information
-
More Information
Article History
Received: 11 September 2018
Accepted: 19 December 2018
First Online: 29 January 2019
Competing interests
: D.A.L. receives support from Roche Diagnostics and Medtronic for research that is unrelated to this study. M.K.R. reports receiving honoraria and consulting fees from Novo Nordisk, Ascensia, Cell Catapult and Roche Diabetes Care. K.V.A. received support from SANOFI-Aventis for research that is unrelated to this study. D.A.H. and 2.R.T. are employees of, and hold stock or stock options in, 23andMe Inc. The remaining authors declare no competing interests.
